To include your compound in the COVID-19 Resource Center, submit it here.

Valeant expects to resolve manufacturing issues

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) said late Wednesday that the CGMP inspection issues identified at its Bausch + Lomb manufacturing facility in Tampa, Fla., will soon

Read the full 273 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE